Please login to the form below

Not currently logged in
Email:
Password:

Quintiles

This page shows the latest Quintiles news and features for those working in and with pharma, biotech and healthcare.

IQVIA collaborates with MuleSoft

IQVIA collaborates with MuleSoft

Technology solutions and contract research group IQVIA, formerly known as Quintiles IMS, has formed a strategic alliance with MuleSoft, a software company based in San Francisco, US.

Latest news

  • IQVIA partners with Box IQVIA partners with Box

    In a bid to strengthen its Platforms of Platforms strategy, technology solutions and contract research group IQVIA - formerly known as Quintiles IMS - has partnered with Box, a cloud-based content management

  • QuintilesIMS changes its name to IQVIA QuintilesIMS changes its name to IQVIA

    Its new name maintains parts of its original formation, with the ‘I’representing IMS and the ‘Q’taken from Quintiles. ... The group has a slightly different offering from when it first became QuintilesIMS, which was due to a mega-merger of

  • INC Research to merge with InVentiv Health INC Research to merge with InVentiv Health

    The deal, which is expected to close during the second half of 2017 and values the new at around $7.4bn, comes seven months after the $18bn merger of Quintiles and

  • New healthcare comms agency launched in UK New healthcare comms agency launched in UK

    Health, Lime and Quintiles.

  • ICON boosts leadership teams ICON boosts leadership teams

    He has over 30 years of experience in pharmaceutical and contract research organisation (CRO) roles, joining from Quintiles where he led its global clinical analysis and reporting services group.

More from news
Approximately 12 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • Pulling together Pulling together

    Making sense of the present and future environment for the life science sector in the UK

  • Pushing the accelerator Pushing the accelerator

    Quintiles, the world’s largest contract research organisation, has differentiated itself by providing its customers with a real-time view of clinical trial data so they monitor their progress and quickly

  • The CRM journey: linking CRM to revenue in pharma The CRM journey: linking CRM to revenue in pharma

    A great CRM demands a clear vision and objective for operational efficiency and commercial effectiveness

  • Getting below the surface: regional and local market access Getting below the surface: regional and local market access

    Quintiles' expertise in market access, built up over many years and in many countries, is based on its network of experienced field-based subnational staff, stakeholders and key opinion leaders. ... Jeremy Broadis is vice president, global commercial

  • Deal Watch May 2016 Deal Watch May 2016

    Deal Watch May 2016. Novartis, Quintiles and Sanofi are among those featured in this month’ s round-up of pharma deal activity. ... Doing the complete opposite and consolidating, Quintiles and IMS Health announced the merger of their respective

More from intelligence
Approximately 4 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 21 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics